BLOCKADE OF ANGIOTENSIN II TYPE I RECEPTOR (AT1) AND CC CHEMOKINE RECEPTOR 2 (CCR2) HETEROMERS IN PROGRESSIVE CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Zhang, Y. [1 ]
Kelly, R. [1 ]
Cox, A. [1 ]
Williams, J.
Mccall, L.
Pfleger, K. [2 ]
Kelly, D. [1 ]
机构：
[1] Univ Melbourne, Melbourne, Vic 3010, Australia
[2] Univ Western Australia, Nedlands, WA 6009, Australia
来源：
NEPHROLOGY | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
083
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [21] Addition of Angiotensin II Type 1 Receptor Blocker to CCR2 Antagonist Markedly Attenuates Crescentic Glomerulonephritis
    Urushihara, Maki
    Ohashi, Naro
    Miyata, Kayoko
    Satou, Ryousuke
    Acres, Omar W.
    Kobori, Hiroyuki
    HYPERTENSION, 2011, 57 (03) : 586 - U430
  • [22] Angiotensin AT2 receptor stimulation enhances cardiovascular effects of chronic AT1 receptor blockade in SHR
    Jones, ES
    Black, MJ
    Widdop, RE
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 39 (03) : 576 - 577
  • [23] Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease
    She, Shaoping
    Ren, Liying
    Chen, Pu
    Wang, Mingyang
    Chen, Dongbo
    Wang, Ying
    Chen, Hongsong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] The angiotensin II type 2 receptor and the kidney
    Siragy, Helmy M.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2010, 11 (01) : 33 - 36
  • [25] Benzimidazoles as benzamide replacements within cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists
    Cherney, Robert J.
    Mo, Ruowei
    Meyer, Dayton T.
    Pechulis, Anthony D.
    Guaciaro, Michael A.
    Lo, Yvonne C.
    Yang, Gengjie
    Miller, Persymphonie B.
    Scherle, Peggy A.
    Zhao, Qihong
    Cvijic, Mary Ellen
    Barrish, Joel C.
    Decicco, Carl P.
    Carter, Percy H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (19) : 6181 - 6184
  • [26] Potent and selective CC-chemokine receptor-2 (CCR2) antagonists as a potential treatment for asthma
    Lagu, Bharat
    Gerchak, Chrissy
    Pan, Meng
    Hou, Cuifen
    Singer, Monica
    Malaviya, Ravi
    Matheis, Michele
    Olini, Gil
    Cavender, Druie
    Wachter, Michael
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (15) : 4382 - 4386
  • [27] Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2)
    Yang, Michael G.
    Xiao, Zili
    Shi, Qing
    Cherney, Robert J.
    Tebben, Andrew J.
    De Lucca, George V.
    Santella, Joseph B., III
    Mo, Ruowei
    Cvijic, Mary Ellen
    Zhao, Qihong
    Barrish, Joel C.
    Carter, Percy H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (03) : 1384 - 1387
  • [28] Design and synthesis of 2-substituted cyclohexylaminobenzamide-derived inhibitors of CC Chemokine Receptor 2 (CCR2)
    Yang, Michael G.
    Barrish, Joel C.
    Batt, Douglas G.
    Brown, Gregory
    Chen, Bang-Chi
    Cherney, Robert J.
    Cvijic, MaryEllen
    Delucca, George V.
    Duncia, John V.
    Gardner, Daniel S.
    Santella, Joseph B.
    Shi, Qing
    Srivastava, Anurag
    Wang, Bei
    Xiao, Zili
    Zhao, Qihong
    Zhao, Rulin
    Carter, Percy H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [29] Angiotensin type 1 and type 2 receptor blockade in chronic allograft nephropathy
    Lutz, J.
    Risch, K.
    Liu, S.
    Antus, B.
    Schmaderer, C.
    Roos, M.
    Ouyang, N.
    Lehmann, M.
    Heemann, U.
    KIDNEY INTERNATIONAL, 2006, 70 (06) : 1080 - 1088
  • [30] Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice
    Wu, L
    Iwai, M
    Nakagami, H
    Chen, R
    Suzuki, J
    Akishita, M
    de Gasparo, M
    Horiuchi, M
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (01) : 49 - 54
12345